share_log

Stephens & Co. Initiates Coverage On Medifast With Equal-Weight Rating, Announces Price Target of $82

Stephens & Co. Initiates Coverage On Medifast With Equal-Weight Rating, Announces Price Target of $82

Stephens & Co.以同等權重評級開始對Medifast進行報道,宣佈目標價爲82美元
Benzinga ·  2023/10/13 17:00

Stephens & Co. analyst Jim Salera initiates coverage on Medifast (NYSE:MED) with a Equal-Weight rating and announces Price Target of $82.

Stephens&Co.分析師吉姆·薩萊拉在Medifast(紐約證券交易所代碼:MED)上以同等權重評級發起報道,並宣佈目標價為82美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論